Cargando…

COVID-19 en pediatría: valoración crítica de la evidencia

We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: González Rodríguez, Paz, Pérez-Moneo Agapito, Begoña, Albi Rodríguez, María Salomé, Aizpurua Galdeano, Pilar, Aparicio Rodrigo, María, Fernández Rodríguez, María Mercedes, Esparza Olcina, María Jesús, Ochoa Sangrador, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asociación Española de Pediatría. Published by Elsevier España, S.L.U. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173476/
http://dx.doi.org/10.1016/j.anpedi.2021.05.019
Descripción
Sumario:We present the summary of a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology. The document tries to provide answers to a series of structured clinical questions, with an explicit definition of the population, intervention/exposure, comparison and outcome, and a rating of the clinical relevance of the outcome measures. We conducted a systematic review of the literature to answer the questions, grouped into six chapters: epidemiology, clinical practice, diagnosis, treatment, prevention, and vaccination. We assessed the risk of bias of the selected studies with standard instruments (RoB-2, ROBINS-I, QUADAS and Newcastle-Ottawa). We constructed evidence tables and, when necessary and possible, meta-analysis of the of the most relevant outcome measures. We followed the GRADE system to synthesize the evidence, assessing its quality, and, when appropriate, giving recommendations, rated according to the quality of the evidence, the values and preferences, the balance between benefits, risks and costs, equity and feasibility.